Tagungen und Workshops zum Thema Onkologie

ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic

The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

WMA GmbH Congress Office;     Tel.: [+431405138318];     Email: itoc@medacad.org

Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy

Immunologie und Allergie,    Pharmakologie und Arzneimittelentwicklung

Binaytara Foundation

The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer care. The summit will feature lectures, discussions and presidential-style debates among leaders across the spectrum of healthcare delivery. It is our hope that this summit will lead us in a direction to help thousands of cancer patients and their families who are still deprived of cutting-edge cancer treatment.

Tel.: [4255575953];     Email: support@binayfoundation.org

Thomas Jefferson University, Office of Continuing Professional Development

The 2nd Annual Head and Neck Cancer Symposium: A Multidisciplinary Approach offers participants an active learning format featuring didactic lectures, panel discussions that will include audience interaction, patient cases, and updates on clinical findings on diagnosis, treatment and management plans for patients with head and neck cancer. Participants will be able to examine head and neck cancer cases from multiple perspectives with a multidisciplinary approach to care.

Jefferson CPD;     Tel.: [2159556992];     Email: jeffersoncpd@jefferson.edu

oncology, head and neck cancer, cancer, cme, philadelphia

Hals-Nasen-Ohren-Heilkunde,    Fortbildung für Gesundheitsfachberufe (CME)

Epigenetics is a field that impinges on many biological processes since it encompasses fundamental mechanisms of gene regulation. In addition, this area is currently exploited for drug development, particularly against cancer, since epigenetics regulators are miss-regulated in this disease. The conference will bring together all these themes. It will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. There will be sessions on Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

Epigenetics, Cancer, Chromatin regulatory pathways, RNA modification pathways, DNA modification pathways, Drug discovery

Genomforschung und Bioinformatik,    Pharmakologie und Arzneimittelentwicklung

The University of Texas MD Anderson Cancer Center & Peter MacCallum Cancer Centre

MD Anderson Cancer Center - Global Academic Programs (GAP) 2020 Conference is a forum where MD Anderson Cancer Center and its global network of hospitals, health systems and research institutions collaborate to develop impactful, innovative ideas and research that help MD Anderson achieve its mission to end cancer globally. This three-day scientific conference centres our attention on the theme – New Frontiers – Leading Inspired Cancer Care. We are looking forward to highlighting global collaborations that bring to light clinical and translational research, population health and government engagement initiatives.

Tel.: [03 6234 7844];     Email: jodi@laevents.com.au

Immunology | The Leading Frontier, Tele Trials, Shared Care, Beyond the Walls | Maintaining a Work / Life Balance, Surviving Translation | Keeping up and Connecting, Facing the Future | Robotics, AI, Deep Machine Learning, Prehabilitation

Justus-Liebig-Universität Gießen

We proudly and cordially invite you to the upcoming „4th International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma“ to be held 13-16 May, 2020 in Berlin, Germany. This important symposium has now almost become a tradition for scientists, clinicians, pharmacists, clinical trial staff, and all people who are involved in the science, diagnosis, and treatment of young people with Hodgkin lymphoma. We are putting together, in collaboration with our fantastic Scientific Committee, a high-quality program with renowned international speakers and experts in the field of Hodgkin lymphoma. We will have two and a half days dedicated to ten main Session Topics, who are now open for abstract submission. We will have interactive case discussions as an opener of most session topics. High-level poster presentations will have the opportunity to advertise their poster via poster pitches in the respective main sessions. One of the highlights will be the awarding of the Günther-Schellong-Price, which will be conferred for the third time. The Scientific Symposium will close with the Abstract Award Session. It is our utmost pleasure to serve again with a major symposium for this great global network for advancing the science and development of standards of care for children, adolescents and young adults with Hodgkin lymphoma. Thus, your attendance at the symposium, will contribute for this well-established network to continue, and you will have the chance to experience the spirit and the action that this great collaboration enables in providing long-lasting cures for all children, adolescents and young adults with Hodgkin lymphoma.

Conference office / Registration;     Tel.: [+49 40 30770 300];     Email: iscayahl@csihamburg.de

advancing science, advancing development, standards of care for children, adolescents and young adults with Hodgkin lymphoma, Hodgkin lymphoma, diagnosis and treatment of young people with Hodgkin lymphoma

Over the last few years, the myeloma field has made significant progresses. We have seen fascinating novel drugs being introduced (including innovative cellular therapies), and the whole treatment paradigm is progressively changing.

Like the previous ones, this international meeting aims to deliver state of the art science and research, focused on the latest advances in the field and on improving patient care.

The scientific content will be on the cutting-edge one because the pace of change in multiple myeloma is accelerating.

In addition to the science, you will be able to enjoy this most spectacular city of Paris. We are looking forward to seeing you in Paris next year

Tel.: [+972528887612];     Email: moran@cme-congresses.com

Multiple Myeloma, cancer, CAR T Cell

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Molecular pathology is revolutionising clinical practice in oncology and pathology paving the way for precision medicine, and has evolved into a growing research field. Knowledgeable molecular pathologists are a significant bottle neck for advancing cancer research and patient care. This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology in research and in clinical settings. The potential uses of deep learning in pathology will be discussed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.

Email: laura.strachan@eacr.org

Molecular pathology, cancer research, oncology

Oxford Global Conferences

Immuno-Oncology, Cancer Immunology, Cancer Vaccines, Immunotherapy, Oncology Cell Therapy, Antibody Development, T-Cell Engineering, Immune Biology, Combination Therapy, CAR-T Cell Therapy, Checkpoint Inhibitors, Bispecific, Assay Development, Cancer Genetics/Genomics, Personalised Medicine, Biomarker, Translational Immunology, Preclinical Development, Clinical Oncology, Clinical Trial Management, Clinical Development

German Cancer Reseach Center Heidleberg (DKFZ) and University Hospital Heidelberg

The fast technological development and the rapid clinical implementation of MRI for radiotherapy applications is currently one of the most exciting as well as most challenging developments in radiation oncology. With this science symposium we would not only like to bring together specialists from all involved disciplines, but also to foster a discussion about the scientific direction of the field. The latest developments in physics and technology of MR-guided radiotherapy as well as clinical directions and results will be presented.

Tel.: [+49 6221 423481];     Email: mrinrthd@dkfz-heidelberg.de

MR guidance, image guidance, adaptive radiotherapy, MR imaging, functionall imaging and others

Biophysik,    Radiologie:Kernspintomographie

Wir freuen uns sehr, Sie zur 3. gemeinsamen Jahrestagung der Mitteldeutschen Gesellschaft für Gastroenterologie (MGG) und der Mitteldeutschen Chirurgenvereinigung (MDCV), dem 3. Mitteldeutschen Pflegesymposium und dem 9. Symposium Junge Chirurgen in Mitteldeutschland in Dresden zu begrüßen. Nach den erfolgreichen gemeinsamen Kongressen 2018 in Leipzig und 2019 in Halle wollen wir das interdisziplinäre Profil des wissenschaftlichen Programms weiter stärken. Gemäß unserem Kongressmotto „Innovationen für die Praxis“ haben wir zeitgemäße Themenschwerpunkte in den Bereichen innovativer operativer und gastroenterologischer Therapien, der Onkologie, bei seltenen und bei entzündlichen Erkrankungen des Gastrointestinaltrakts, sowie dem immer relevanteren metabolischen Syndrom gesetzt. Besonders wichtig ist es uns, die Interessen der jungen Chirurgen und jungen Gastroenterologen in unserem Programm abzubilden. Wir freuen uns auf Ihre zahlreiche Teilnahme in den dezidierten Sitzungen und praktischen Workshops unter anderem in den Bereichen Robotik, Naht und Darmsonographie. Herausragende Leistungen würdigen wir traditionell durch die im Rahmen des Gesellschaftsabends verliehenen Posterpreise. Wir finden, Viszeralmedizin ist Teamwork. Daher steht die Einbeziehung der Pflege mit dem bewährten Pflegesymposium wieder auf dem Programm und soll in interdisziplinären Workshops weiter gestärkt werden.

event lab. GmbH;     Tel.: [0341-30888464];     Email: tbaehr@eventlab.org

Gastroenterologie, Chirurgie, Onkologie, Robotik und Digitalisierung, Darmsonographie, Naht, Viszeralmedizin, Kolorektales Karzinom, Pankreaskarzinom, Leberversagen, CED, Endoskopische Innovationen, Tracheo/ Bronchoösophageale Fisteln, Unfallchirurgie, Kinderchirurgie, Gefäßchirurgie, Viszerale Palliativmedizin, Chronische Pankreatitis, Refluxerkrankungen

Gastroenterologie,    Chirurgie

wikonect GmbH

The management of cholangiocarcinoma remains a major challenge. With the establishment of modern surgical, interventional and systemic treatment options over the last few years, the treatment of cholangiocarcinoma more than ever requires an interdisciplinary approach and open dialogue. Therefore, the 3rd International Expert Meeting in Mainz will bring together renowned specialists in the field of surgery, medical oncology, pathology, endoscopy, diagnostic and interventional radiology as well as radiotherapy. Experts from all around the world will meet in Mainz for an intensive two-day discussion on diverse aspects of cholangiocarcinoma. The program 2020 comprises most relevant topics and critical issues on the diagnosis and management of intrahepatic, perihilar as well as distal cholangiocarcinoma: as observed in other cancer types, molecular profiling has started to gain increasing relevance in the treatment of advanced cholangiocarcinoma. Moreover, novel diagnostic approaches as well as tools for local therapy have been developed, which require particular attention. Furthermore, controversies on the optimal preoperative work-up including biliary drainage as well as potential indications for neoadjuvant and adjuvant targeted therapy will be major topics. Also, IgG4-associated cholangitis and Klatskin-mimicking lesions that are still highly difficult differential diagnoses and pose major therapeutical problems will be highlighted. Finally, operative techniques, pitfalls in surgery and surgical strategies are presented focusing on vascular resection, the laparoscopic and robotic approach as well as ALPPS.

wikonect GmbH;     Tel.: [+49 611 204 809 242];     Email: info@wikonect.de

Chirurgie,    Radiologie (allgem.)

Abcam

​This conference will cover the basic and latest aspects of the metabolic transformation in cancer and will highlight potential therapeutic approaches to target cancer-specific metabolic pathways.

Abcam Events Team;     Email: events@abcam.com

metabolism, cancer, cancer/metabolism

EACR 2020 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Email: hello@eacr2020.org

Artificial Intelligence, Cancer Genomics, Immuno Genomics, Cancer Models, Metastasis, Lineages, DNA Damage, Vital Imaging, Metabolism, Microbes

AECSMED

It is the only course targeted to practicality of day to day practice. Real life case discussion and hands on training. Learn out patient loop cone and needle cone (netz/swetz) for advanced cases on state of the art simulators with Mr. Khan the leading ambulatory gynaecologist from london.

APPROVED BY : BSCCP – British Society for Colposcopy and Cervical Pathology

Tel.: [+971555322030];     Email: aecsmedicals@gmail.com

colposcopy, gynaecologist, Masters Certification In Colposcopy, basic colposcopy, Advance colposcopy

Gastroenterologie,    Fortbildung für Gesundheitsfachberufe (CME)

ESOI (European Society of Oncologic Imaging)

The Oncologic Imaging Course (OIC), established in 2011, is an annual oncologic imaging course jointly organised by the European Society of Oncologic Imaging, the Department of Radiology at Memorial Sloan Kettering Cancer Center, the Department of Radiology at Ludwig Maximilians University Munich and the Department of Biomedical Imaging and Image­Guided Therapy at the Medical University of Vienna. OIC welcomes the most qualified faculty who comprise of internationally renowned speakers.These experts share their expertise with the participants who are also invited to actively contribute to the sessions with their experience and advice. Those involved in the field of oncologic imaging are experiencing a time of increasing pressure, stress and change. The demand for efficiency and effectiveness in all oncologic imaging matters is constantly growing. OIC addresses current challenges and provides a forum for education and the exchange of ideas and concepts. The course furthermore deals with supportive methods and techniques so the delegates will leave with new ideas for their day-to-day practice. OIC involves lectures, workshops, interactive case discussions and panel discussions.

ESOI Office;     Tel.: [+4315334064924];     Email: office@esoi-society.org

Radiologie (allgem.),    Fortbildung für Gesundheitsfachberufe (CME)

MCI Deutschland GmbH

Organizer;     Tel.: [+49 30 204590];     Email: degro@mci-group.com

Ultra-High Dose Rates, Hypofractionation in curative therapy, Oligoma Tastasis, Synergies with Immunotherapy, Artificial Intelligence and Radiomics, MRI-guided Radiation Therapy, DEGRO: The First 25 Years; the next 25 years, Brachytherapy: Status and Development

Südwestdeutsche Gesellschaft für Gastroenterologie

Kongress- und Kulturmanagement GmbH;     Tel.: [+49 3643 2468-157];     Email: antje.sauter@kukm.de

Gastroenterologie, Innere Medizin, Hepatologie, Endoskopie, gastroinstestinale Onkolgie, Onkologie, CED, Pankreas

Gastroenterologie,    Hepatologie

ICECT 2020

International Conference and Exhibition of Cancer & Therapeutics" (Cancer London 2020) invites all the delegates to our upcoming conference which is going to be held in London, UK during July 6 - 8, 2020. The theme of ICECT 2020 conference is “Cancer Current Research & Treatments

Email: cancer_cong@cancerlondonconf.com

Cancer London 2020

Knowing how cells respond to DNA damage is critical to our understanding of tumourigenesis, genomic instability, and the cellular response to DNA-damaging chemotherapy and radiotherapy. DNA damage responses take place in the context of chromatin and in the midst of ongoing transcription and replication. Moreover, the metabolic environment, which is altered in tumour cells, influences these activities. In this conference, we aim to bring together researchers working on understanding DNA damage responses in the context of complex and dynamic cellular environments. This is an exciting and fast moving area, and this conference features an excellent international line-up of speakers. The programme will address the challenges of understanding this complex field and will emphases new experimental approaches for interrogating these pathways. We will also consider how recent advances can be exploited in the clinic.

DNA damage responses, cancer, oncology, Epigenetic, radiotherapy, transcription, immune, repair, tumourigenesis, cellular, genomic

This conference will focus on three major areas: First, it will present new approaches to generate precise and complex genetic alterations in mice and other animals to better “humanize” models and allow for in vivo studies of cancer gene function. Second, it will highlight studies to investigate fundamental mechanisms of cancer initiation and progression, including the cell of origin of tumors, their evolution, their metabolism, and their interactions with the immune system. Finally, the meeting will explore how genetically engineered animal models can help evaluate the efficacy of novel therapeutic approaches and to decipher mechanisms of therapeutic resistance.

Conference Manager;     Tel.: [00441638724137];     Email: admin@fusion-conferences.com

New technologies for cancer modelling, Modeling pre-cancers and tumor initiation, Cancer metabolism, Cancer/immune interactions and tumor microenvironment, Metastasis, Preclinical trials and resistance, Oncology, Animal Modeling

Biologie,    Translationale Medizin, Klinische Studien

Van Andel Institute

Origins of Cancer is a one-day symposium that brings together students, scientists and medical professionals to discuss the latest breakthroughs in cancer research. This year’s meeting will highlight the tumor macroenvironment, which comprises near and far cells, tissues and systems that interact with primary cancer cells to promote tumor survival. Invited speakers also will discuss novel and integrative treatment approaches that target this larger interactome to outsmart cancer cells.

Email: beth.resau@vai.org

Cancer, Biology, Immuno-oncology, Tumor microenvironment, metabolism, Exosomes, Cancer Therapeutics,

European Association for Cancer Research & European Society of Oncologic Imaging

This new conference is organised by the European Association for Cancer Research (EACR) and the European Society of Oncologic Imaging (ESOI).Our ability to understand and treat cancer is critically dependent upon imaging. This meeting will bring together imaging experts in both clinical and basic research arenas to present their latest research and discuss how to integrate understanding across length scales, imaging modalities, and cancer types. Improved clinical imaging has the power to transform the detection and biologic characterisation of early lesions and the identification of those patients with more advanced disease for tailoring and monitoring personalised therapies. Further, the development of new therapies depends on improved understanding of cancer biology; small animal imaging and imaging tumours with cellular and sub-cellular resolution can elucidate heterogeneity in cancer cell state and interactions with stromal cells, which provide new opportunities for therapeutic intervention. This conference is aimed at clinical and experimental cancer researchers working with, or interested in, the broad range of imaging modalities including US and photoacoustic, CT and micro CT, MRI, PET/CT and PET/MR hybrid imaging, as well as optical techniques. Data analysts dealing with imaging data science using deep learning/machine learning, are also explicitly encouraged to attend.

Email: claire.sullivan@eacr.org

Imaging, Oncology, Machine Learning, Deep Learning, Cancer Biology, Personalised Therapies

The eighth annual meeting of the Society of Hematologic Oncology (SOHO 2020) is scheduled for September 9–12, 2020 at the Hilton Americas, 1600 Lamar St, Houston, Texas 77010. Organized by its founders and world class committees, SOHO is the only international society specific to the field of hematologic malignancies.

Tel.: [+4936413116390];     Email: conferencemarketing@conventus.de

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide hands-on experience in the several techniques to detect and analyse circulating tumor cells (CTCs), cell free tumor DNA (ctDNA) and proteins. Participants will have the opportunity to learn all aspects ranging from proper sampling through error free sequencing to data analysis. Lectures will also cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics.

EMBL Events;     Tel.: [+49 6221 378 8797];     Email: events@embl.de

Hands-on experience on ultra-sensitive mutation detection using sequencing, Applications of digital PCR to the liquid biopsy workflow, Protein analysis in liquid biopsis, Data analysis and interpretations

Medizin (allgem.),    Analysis

Tel.: [+4936413116390];     Email: conferencemarketing@conventus.de

We are delighted to invite you to participate in the 3rd Annual Meeting of the International Academy for Clinical Hematology (IACH): Focus on Leukemia, taking place October 1-3, 2020 in Nice, France.Our 3rd edition will focus on leukemia in a format that allocates a significant amount of time to interactive debates and audience questions to the expert panels. Participants are encouraged to take an active role in the discussions with faculty members in this unique open environment.

Tel.: [+972528887612];     Email: moran@cme-congresses.com

Leukemia, CAR T Cell therapy

Hämatologie,    Stammzellforschung und -therapie

The 2nd EACR Conference on Mechanisms to Therapies: Innovations in Cancer Metabolism will gather top experts in the field to discuss the metabolic alterations in tumours and how we can exploit it to treat cancer.

Email: laura.strachan@eacr.org

Deutsche Gesellschaft für Neuroradiologie e.V.

Das Motto des neuroRAD 2020 Neue Arbeitswelten transportiert etwas von dem enormen gesellschaftlichen Wandel, in dem Ärztinnen und Ärzte wirken.

Kongress- und Kulturmanagement GmbH;     Tel.: [+49 3643 2468 157];     Email: antje.sauter@kukm.de

Neuroradiologie, Interventionelle Neuroradiologie, Neuroonkologie, Neurodegenerative Erkrankungen

The purpose of the International Symposium on Mathematical and Computational Oncology (ISMCO) is to provide a common interdisciplinary forum for mathematicians, scientists, engineers and clinical oncologists to present and discuss the latest research findings, ideas, developments and applications in mathematical and computational oncology. In particular, ISMCO aspires to enable the forging of stronger relationships among mathematics and physical sciences, computer science, data science, engineering and oncology with the goal of developing new insights into the pathogenesis and treatment of malignancies. The symposium will consist of invited and contributed presentations (oral and poster) dealing with all aspects of mathematical and computational oncology. There will also be several keynote presentations, tutorials, special tracks, and panel discussions.

Publicity Chair;     Email: jpetereit@unr.edu

cancer, big data, ML, computer vision, high-throughput, systems biology, interdisciplinary, HPC, precision medicine

EHOC 2020 will fill in a significant gap in our region and serve not only scientifically but also culturally.

Melton Medical Education, LLC

Over the past two decades, this meeting has become the premier forum for discussion of the diagnosis and treatment of myeloproliferative neoplasms (MPNs), providing timely, relevant and meaningful information to attendees from around the world.

Tel.: [5126195534];     Email: info@meltonmeded.com

myeloproliferative neoplasm, MPN, PV, CML, ET, Mastocytosis, CMMol, thrombocytosis, hematopoiesis, Hypereosinophilias, MF, myelofibrosis, JAK2, CME, NY, Silver

Fortbildung für Gesundheitsfachberufe (CME),    Hämatologie

Become Part of the leading European Congress on Hematological Malignancies: The European Society for Translational Medicine EUSTM cordially invites you to attend the 7th Annual Congress of the European Society for Translational Medicine on Hematologic Malignancies EUSTM-2020 from 3-4 November, 2020 in Budapest, Hungary.

Tel.: [+43 1 8923 562];     Email: eustm-2020@eutranslationalmedicine.org

Acute Leukemias, ALL & AML, Chronic Lymphocytic Leukemia CLL, Chronic Myeloid Leukemia CML, Myeloproliferative Neoplasms, Multiple Myeloma, Myelodysplastic Syndromes, MDS, Non-Hodgkin lymphoma, Hodgkin Lymphoma, Others

ESOI (European Society of Oncologic Imaging)

The ESOI/EORTC workshop is an interactive hands-on course aimed at practising radiologists and radiology residents, focusing on the criteria-based assessment of tumour response to treatment. The course consists of a number of lectures explaining the principles of imaging-based tumour response assessment and several hands-on interactive training workshops using specialised software with common and rare cancer cases encountered in the clinical routine or within clinical trials.

ESOI Office;     Tel.: [+4315334064924];     Email: office@esoi-society.org

Radiologie (allgem.),    Fortbildung für Gesundheitsfachberufe (CME)

Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Cancer Center of the University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. This year’s conference will focus on tumor microenvironment, cell-based therapy in hematology and oncology, immune checkpoint inhibitors, biomarkers, cell therapies and cancer vaccines.

Fraunhofer Institute for Cell Therapy and Immunology;     Tel.: [+49 341 35536-9320];     Email: info@lion-conference.com

oncology, immunology, hematology, biomarkers, immunotherapy, cell therapies, cancer vaccines

Immunologie und Allergie,    Hämatologie

The New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.)

The New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.) is organising the second New Zealand Breast Cancer Symposium in 2020 (NZBCS-2020), which will be held in Auckland, New Zealand from 12-14th November 2020.

Chair, the Organising Committee of NZBCS-2020;     Tel.: [0064-9-921 9999];     Email: nzbcs@aut.ac.nz

Breast Cancer, New Zealand, NZBCS, NZBCS-2020, NZABCR, Auckland, Symposium, Biomarker, Targeted Therapy, Immunotherapy

European Association for Cancer Research

This meeting aims to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse. It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice.

Email: claire.sullivan@eacr.org

Liquid Biopsies, Biopsies, Tumor cells, Early detection of cancer, nucleic acids, biomarkers

European Association for Cancer Research

Following the highly successful first and second edition, Defence is the Best Attack 2021 will be the third EACR conference on this topic. In this conference, we will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Laura Strachan;     Email: laura.strachan@eacr.org

immunotherapy, immuno-oncology, biomarkers, Vaccination

Tel.: [+4936413116390];     Email: julia.wrenczycki@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de